Hamill John P. — SEC Form 4 filings
SEC reporting owner CIK 1716213. 9 Form 4 filings on record with FilingPulse; latest filed 2026-04-01.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-03-14 to 2026-04-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 12,210 shares, $19,559 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 1,010 shares @ $7.29 ($7,363) in Aprea Therapeutics, Inc., filed 2024-03-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | SrVP/CFO/Prin Fin & Acct Ofcr | 9 | 5 legs · 12,210 sh · $19,559 | — | 12 |
Form 4 filings — Hamill John P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-01 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 30,978 (derivative) @ $0.81 · Purchase (P): 30,978 (derivative) | EDGAR |
| 2026-03-16 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 10,095 @ $0 · Grant/award (A): 40,380 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 5,700 @ $0.89 · Purchase (P): 5,700 (derivative) | EDGAR |
| 2025-12-11 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 5,000 @ $1.17 · Purchase (P): 5,000 (derivative) | EDGAR |
| 2025-03-31 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 3,365 @ $0 · Grant/award (A): 13,460 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 50 @ $2.46 | EDGAR |
| 2024-10-15 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 450 @ $2.61 | EDGAR |
| 2024-03-28 | 4 | Aprea Therapeutics, Inc. (APRE) | Grant/award (A): 3,365 @ $0 · Grant/award (A): 13,460 (derivative) @ $0 | EDGAR |
| 2024-03-14 | 4 | Aprea Therapeutics, Inc. (APRE) | Purchase (P): 1,010 @ $7.29 · Purchase (P): 505 (derivative) · Purchase (P): 505 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1716213 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →